07:16 EDT Neurocrine backs FY24 INGREZZA net product sales view $2.1B-$2.2B
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NBIX:
- Neurocrine Biosciences Reports First Quarter 2024 Financial Results
- NBIX Upcoming Earnings Report: What to Expect?
- Tesla, Airbnb upgraded: Wall Street’s top analyst calls
- Wells Fargo upgrades Neurocrine with pipeline ‘turning a corner’
- Neurocrine upgraded to Overweight from Equal Weight at Wells Fargo